论文部分内容阅读
Objective: The aim of the study was to investigate the clinical effects of concurrent radiochemotherapy in treating while Group CCRT was delivered three cycles chemotherapy of PF (DDP + 5-Fu) regimen or PLF (DDP + 5-Fu + CF) regimen.Results: The complete remission rate and total remission rate of Group CCRT were higher than those of Group RT, and the by life table method, in Group CCRT, it was higher than that of Group RT and the difference was of statistical importance (χ2= 4.24, P < 0.05). The 3-year overall survival (OS) rate, nasopharyngeal control rate and cervical lymph nodes control rate < 0.05). The 5-year overall survival (OS) rate and metastasis-free rate of Group CCRT were higher than those of Group RT CCRT were obviously higher than those in Group RT, and the difference of gastrointestinal reaction was of statistical importance (χ2 = 11.70, P < 0.05). Conclusion: This study has demonstrated that concurrent radiochemotherapy can improve the remission rate, overall survival rate and locally control rate. The toxicities of concurrent radiochemotherapy can be tolerated by the patients.